文献速递糖尿病

尿结合珠蛋白与2型糖尿病患者全因及病因特异性死亡风险的关联:一项跨种族合作研究

Association of Urine Haptoglobin With Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Transethnic Collaborative Work.
PubMed 文献 · Diabetes Care · 2019-12-20

本研究采用跨种族设计,纳入新加坡亚裔队列(N=2,061)和法国SURDIAGENE欧洲裔队列(N=1,438),分析尿结合珠蛋白与2型糖尿病患者全因及病因特异性死亡风险的关联。新加坡队列中第4四分位尿结合珠蛋白者全因死亡风险在多变量校正后仍显著升高(校正HR 1.68 [95%CI 1.15-2.45]),法国队列第4四分位校正HR为1.49(1.14-1.96)。两队列第4四分位者心血管疾病和感染相关死亡风险更高,但恶性肿瘤死亡风险未见升高。

要点

  • 新加坡队列尿结合珠蛋白第2至4四分位全因死亡未校正HR分别为1.47、2.28和4.64,第4四分位校正后HR为1.68。
  • 法国队列尿结合珠蛋白第4四分位全因死亡未校正HR为2.67,校正后HR为1.49(95%CI 1.14-1.96)。
  • 两队列第4四分位者心血管疾病和感染相关死亡风险更高,恶性肿瘤死亡风险未升高。

核心结论

  • 尿结合珠蛋白可独立于传统危险因素预测2型糖尿病患者的死亡风险,可能成为死亡风险的新型生物标志物。

研究设计与样本

  • 跨种族合作研究,纳入新加坡亚裔队列(N=2,061)和法国SURDIAGENE欧洲裔队列(N=1,438),采用生存分析研究尿结合珠蛋白与全因及病因特异性死亡风险的关联。

主要发现

  • 新加坡队列中位随访7.5年(四分位距3.5-12.8),共登记365例死亡;法国SURDIAGENE队列中位随访6.8年(四分位距4.3-10.5),共登记525例死亡。
  • 新加坡队列尿结合珠蛋白第2至4四分位者全因死亡风险高于第1四分位,未校正HR分别为1.47(95%CI 1.02-2.11)、2.28(1.62-3.21)和4.64(3.39-6.35)。
  • 新加坡队列第4四分位者多变量校正后全因死亡风险仍显著升高,校正HR为1.68(95%CI 1.15-2.45)。
  • 法国队列尿结合珠蛋白第4四分位者全因死亡风险高于第1四分位,未校正HR为2.67(95%CI 2.09-3.42),校正HR为1.49(1.14-1.96)。
  • 两队列第4四分位者心血管疾病和感染相关死亡风险更高,但恶性肿瘤死亡风险未升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Haptoglobin is an acute-phase reactant with pleiotropic functions. We aimed to study whether urine haptoglobin may predict risk of mortality in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We employed a transethnic approach with a cohort of Asian origin (Singapore) (N = 2,061) and a cohort of European origin (France) (N = 1,438) included in the study. We used survival analyses to study the association of urine haptoglobin with risk of all-cause and cause-specific mortality. RESULTS: A total of 365 and 525 deaths were registered in the Singapore cohort (median follow-up 7.5 years [interquartile range 3.5-12.8]) and French SURDIAGENE cohort (median follow-up 6.8 years [interquartile range 4.3-10.5], respectively. Singapore participants with urine haptoglobin in quartiles 2 to 4 had higher risk for all-cause mortality compared with quartile 1 (unadjusted hazard ratio [HR] 1.47 [95% CI 1.02-2.11], 2.28 [1.62-3.21], and 4.64 [3.39-6.35], respectively). The association remained significant in quartile 4 after multiple adjustments (1.68 [1.15-2.45]). Similarly, participants in the French cohort with haptoglobin in quartile 4 had significantly higher hazards for all-cause mortality compared with quartile 1 (unadjusted HR 2.67 [2.09-3.42] and adjusted HR 1.49 [1.14-1.96]). In both cohorts, participants in quartile 4 had a higher risk of mortality attributable to cardiovascular disease and infection but not malignant tumor. CONCLUSIONS: Urine haptoglobin predicts risk of mortality independent of traditional risk factors, suggesting that it may potentially be a novel biomarker for risk of mortality in patients with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Liu JJ, Liu S, Saulnier PJ, et al. Association of Urine Haptoglobin With Risk of All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes: A Transethnic Collaborative Work. Diabetes Care. 2019. PMID: 31862788. doi:10.2337/dc19-1295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。